Every few months, someone messages me asking a version of the same question. A brother, a partner, a grown child has been diagnosed with schizophrenia or a schizoaffective condition. Nothing conventional has worked, or the side effects have hollowed them out, and someone in the family has read a hopeful thread online about ayahuasca. Could plant medicine help? Could a ceremony do what years of medication haven't?

I understand the pull of that question. When you've watched someone you love disappear into an illness that modern psychiatry manages but rarely cures, the idea of a plant that reorders consciousness sounds like a door worth trying. But I want to be honest with you before you spend money, book a flight, or persuade anyone into a maloca in the Amazon. The relationship between ayahuasca, psychedelics, and schizophrenia is not what the more romantic corners of the internet suggest. It's one of the few areas where the plant-medicine world is close to unanimous, and where I think the caution is earned.

Why Ayahuasca and Psychosis Are a Dangerous Pairing

Ayahuasca contains DMT, a powerful serotonergic psychedelic, combined with MAO inhibitors from the caapi vine. What that means in practice is a several-hour experience where perception, memory, ego structure, and sensory input all come loose at once. For a healthy nervous system, that unmooring can be therapeutic. For a brain already prone to psychosis, it can be genuinely destabilizing — sometimes for weeks, sometimes for longer.

Most serious retreats will not accept participants with a personal or first-degree family history of schizophrenia, schizoaffective disorder, or bipolar I. This isn't squeamishness. It's because classical psychedelics can trigger or worsen psychotic episodes in vulnerable individuals, and the mechanism — flooding an already dysregulated serotonin and dopamine system — is exactly the opposite of what antipsychotic medication tries to do. If a retreat tells you their brew is safe for someone with active schizophrenia, that's a red flag the size of a canoe. Walk away.

There's also the practical problem of MAOIs. Ayahuasca's monoamine oxidase inhibitors interact badly with most antipsychotics, SSRIs, and mood stabilizers. Discontinuing those medications to prepare for a ceremony can itself trigger relapse. This isn't a theoretical worry — I've heard the stories, and so has anyone who's spent time in this world long enough.

The Hopeful Anecdotes You've Probably Read

Now, to be fair. There are stories. There are always stories. Someone's cousin's friend went to Peru, sat with the medicine, and came home lucid for the first time in a decade. Reddit threads, YouTube testimonials, a documentary or two. I'm not going to tell you these are all fabricated. Some of them likely happened, in some form.

But here's what I've learned from covering this beat for years: the person telling the story is almost never a clinician, the diagnosis is often self-reported or family-reported, and follow-up beyond a few euphoric months is rare. Psychosis has natural remission windows. Placebo effects around dramatic, meaningful experiences are enormous. And selection bias in these communities is intense — the people who had catastrophic experiences don't usually come back to post updates. They're recovering, or their families are grieving, and neither group is scrolling forums.

None of that means every positive account is worthless. It means you should treat them the way you'd treat a friend's tip on a stock — interesting, worth noting, absolutely not a basis for betting your life savings.

What the Research Actually Shows

Serious clinical work on psychedelics has advanced dramatically in the last five years, but it has almost entirely bracketed out schizophrenia-spectrum disorders. When you read a headline about psilocybin helping depression, or MDMA for PTSD, or ayahuasca for treatment-resistant depression — look at the exclusion criteria in the study. Schizophrenia is excluded. Bipolar I is usually excluded. Any personal history of psychosis is excluded. Family history is often excluded too.

This isn't researchers being cautious out of habit. It's because the small existing literature on psychedelics in psychotic-spectrum patients is concerning, and no ethics board is signing off on a trial that could push a stable schizophrenic patient back into acute psychosis. There is a small amount of interest in whether certain compounds might help specific negative symptoms — social withdrawal, flattened affect — but that research is preliminary, closely supervised, and nothing like a weekend ceremony in the jungle.

If you see a retreat marketing ayahuasca as a treatment for schizophrenia, they are ahead of the science by a margin that should worry you.

What About Other Master Plants and Approaches?

People sometimes ask whether other plant medicines — San Pedro, iboga, kambo, psilocybin mushrooms — might be safer than ayahuasca for someone with a serious mental illness. The honest answer for the classical psychedelics (psilocybin, mescaline in San Pedro, DMT) is: no, the same risk profile applies. Iboga has its own cardiovascular concerns and psychiatric contraindications. Kambo is not psychedelic, but it's a strong somatic intervention that reputable practitioners won't offer to people on antipsychotics or in fragile states.

Where I've seen more thoughtful conversations is around adjunct practices that don't involve psychoactive substances at all:

• Somatic and trauma-informed bodywork, which can help with the physical symptoms of chronic stress that often accompany serious mental illness.
• Structured meditation practices under experienced teachers who understand psychotic vulnerability — not open silent retreats, which can themselves destabilize.
• Nutritional psychiatry, sleep-focused interventions, and community-based recovery models like Open Dialogue, which has genuine outcome data in first-episode psychosis.
• Family therapy and psychoeducation, which sound boring next to a jungle ceremony but have decades of evidence behind them.

None of this has the mythic pull of ayahuasca. All of it is more likely to help.

If Someone in Your Life Is Considering This Anyway

Sometimes the person considering the retreat is an adult, they've heard everything you can tell them, and they're going to make their own choice. If that's where you are, here's what I'd want a family member to know.

Be honest with the facilitator during screening. Not partially honest. Fully honest. If a retreat lets someone in without a proper medical intake, that itself tells you what kind of operation it is. Any facilitator worth sitting with will decline participants they can't safely hold, and a decline is a gift, not a rejection.

Understand the medication timeline. Coming off antipsychotics or mood stabilizers to attend a ceremony is a significant medical event, not a lifestyle adjustment. It requires a prescribing psychiatrist, a taper, and a plan for what happens if things go sideways. "I stopped my meds two weeks ago" is not a preparation protocol.

Plan for integration before you plan for the ceremony. The days and weeks after any strong psychedelic experience are when the real work — and the real risk — plays out. For someone with a psychiatric history, integration should include a therapist who knows about the experience, a stable living situation, and someone who can notice early signs of decompensation.

A Quieter Question Underneath

When families ask me about ayahuasca for schizophrenia, there's usually a deeper question hiding underneath. It's not really "will this cure my brother." It's "is there anything left to try, and am I doing enough." I take that question seriously, because I've asked versions of it myself about people I love.

What I've come to believe is that the most useful thing plant medicine offers to families dealing with serious mental illness usually isn't the ceremony. It's the framework — the willingness to think about healing as something communal, embodied, and ongoing rather than a pill-and-appointment transaction. You can adopt that framework without ever drinking the brew. Cook meals together. Walk in the woods regularly. Find a therapist who treats the person, not the diagnosis. Get honest about family patterns. These are unglamorous and slow, and they help.

For readers whose interest in ayahuasca is genuine but who fall outside the risk categories I've described — no personal or family history of psychosis, no medication conflicts, a stable life situation — carefully vetted ayahuasca ceremonies and other plant-medicine retreats can be browsed on our marketplace here. For anyone weighing this on behalf of someone with schizophrenia, my honest advice is to put the plane ticket down and keep reading, keep asking, and keep supporting the person in the ways that actually reach them.